Fujirebio Diagnostics Inc is categorized under Diagnostic Substances in Seguin, TX and active since 2008.
Fujirebio Diagnostics Inc was established in 2008, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 3254130 by the NAICS.
If you are seeking more information, feel free to contact Cecil Toon, Vice President at the company’s single location by writing to 940 Crossroads Boulevard, Seguin, Texas TX 78155 or by phoning (830) 372-1391. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fujirebio Diagnostics Inc |
| Contact Person: | Cecil Toon, Vice President |
| Address: | 940 Crossroads Boulevard, Seguin, Texas 78155 |
| Phone Number: | (830) 372-1391 |
| Website Address: | fdi.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Diagnostic Substances |
| SIC Code: | 2835 |
| NAICS Code: | 3254130 |
| Share This Business: |
Fujirebio Diagnostics Inc was started in 2008 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 3254130. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Cecil Toon, Vice President for inquiries that concern Fujirebio Diagnostics Inc by calling the company number (830) 372-1391, as your correspondence is most welcome. Additionally, the physical location of the single location of Fujirebio Diagnostics Inc can be found at the coordinates 29.59659,-97.95169 as well as the street address 940 Crossroads Boulevard in Seguin, Texas 78155.
For its online presence, you may visit Fujirebio Diagnostics Inc’s website at fdi.com and engage with its social media outlets through on Twitter and on Facebook.